financetom
TDUP
financetom
/
Consumer Discretionary
/
TDUP
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
ThredUp Inc.TDUP
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

ThredUp Inc., together with its subsidiaries, operates an online resale platform in the United States and internationally.

Its platform enables consumers to buy and sell primarily secondhand women's and kids' apparel, shoes, and accessories.

ThredUp Inc. was incorporated in 2009 and is headquartered in Oakland, California.

Latest News >
Southwest Airlines Unveils 3-Year Plan for Revenue Growth, Profitability
Southwest Airlines Unveils 3-Year Plan for Revenue Growth, Profitability
Oct 3, 2024
08:11 AM EDT, 09/26/2024 (MT Newswires) -- Southwest Airlines ( LUV ) on Thursday unveiled a three-year plan to drive revenue growth and return the carrier to industry-leading profitability. Southwest Airlines ( LUV ) said it is planning to introduce assigned seating in the second half of 2025 to broaden its consumer appeal and boost demand. The carrier plans to...
Surge Copper Completes 2024 Field Program at Berg, Ootsa Projects in British Columbia
Surge Copper Completes 2024 Field Program at Berg, Ootsa Projects in British Columbia
Oct 3, 2024
08:02 AM EDT, 09/26/2024 (MT Newswires) -- Surge Copper ( SRGXF ) said Thursday that it completed its 2024 field program at the Berg and Ootsa copper-molybdenum-precious metals projects in British Columbia. As part of the program, the company drilled 5,054 meters comprising 13 diamond drill holes. Assay results are pending. The company said a pre-feasibility level metallurgy program is...
Pasithea Therapeutics Says Interim Phase 1 Data Show Tumor Drug Candidate's Efficacy, Safety; Shares Rise Pre-Bell
Pasithea Therapeutics Says Interim Phase 1 Data Show Tumor Drug Candidate's Efficacy, Safety; Shares Rise Pre-Bell
Oct 3, 2024
07:56 AM EDT, 09/26/2024 (MT Newswires) -- Pasithea Therapeutics ( KTTA ) said Thursday that interim data from a phase 1 study showed that its experimental drug, PAS-004, was effective and safe in treating neurofibromatosis type 1 and other cancer indications. The company said PAS-004's long half-life of about 70 hours enables once-daily or less frequent oral dosing compared with...
Top Premarket Gainers
Top Premarket Gainers
Oct 3, 2024
08:03 AM EDT, 09/26/2024 (MT Newswires) -- Telesis Bio ( TBIO ) shares increased more than two-fold pre-bell Thursday after the company said it teamed up with Beckman Coulter Life Sciences to create scalable biofoundries. Pasithea Therapeutics ( KTTA ) shares surged 64% after the company said that its colorectal cancer drug PAS-004 demonstrated early potential signs of efficacy in...
Copyright 2023-2025 - www.financetom.com All Rights Reserved